Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Xu, H. Tiffany, A. Luquero, F. J. Kanungo, S. Bwire, G. Qadri, F. Garone, D. Ivers, L. C. Lee, E. C. Malembaka, E. B. Mendiboure, V. Bouhenia, M. Breakwell, L. Azman, A. S.
Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis
All age groups Cholera Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Kolsuz, S. Gullu, D. Karahan, K. D. Ergonul, O.
Risk factors and preventive role of vaccination in adult tetanus fatality: a systematic review of reported cases (1990-2024) and meta-analysis
Adults Older adults Tetanus Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Ugwu, C. L. J. Bragazzi, N. L. Wu, J. Kong, J. D. Asgary, A. Orbinski, J. Woldegerima, W. A.
Risk factors associated with human Mpox infection: A systematic review and meta-Analysis
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2025 ∙ Kosmeri, C. Klapas, A. Evripidou, N. Kantza, E. Serbis, A. Siomou, E. Ladomenou, F.
Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis
Children Rotavirus Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Vidya, A. P. Wijaya, N. J. Gathmir, D. Z. P. Kornel, N. A. K. Farhan, M. Sianipar, I. R.
Safety and efficacy of high-dose versus standard-dose influenza vaccines in hematopoietic stem cell transplant recipients: A meta-analysis of randomized controlled trials
All age groups Influenza Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Rezahosseini, O. Bazargan, A. Eiberg, M. F. Korsgaard, A. P. Niyati, R. Ekenberg, C. Nielsen, L. N. Harboe, Z. B.
Safety and Immunogenicity of Co-Administration of Herpes Zoster Vaccines with Other Vaccines in Adults: A Systematic Review and Meta-Analysis
Adults Older adults Herpes zoster Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Bandell, A. Giles, L. Cervelo Bouzo, P. Sibbring, G. C. Maniaci, J. Wojtczak, H. Sokolow, A.
Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment
Children Adolescents Adults Influenza Safety
Rating:
Critically low
2025 ∙ Thone, P. Egger, M. Gruber, M. S. Gruber, G. Kasassov, C. Nyiri, D. Weis, E. Werl, H. Trinkl, L. Lilleby, W. Clodi, M. Brautigam, E. Dieplinger, B. Aigner, A. Geinitz, H.
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation-Oncology Patients: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2025 ∙ Al-omoush, O. Khalil, L. Ramadan, A. Tarakhan, H. Alzoubi, A. Nabil, A. Hajali, M. Abdelazeem, B. Saleh, O.
Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series
All age groups COVID-19 Safety
Rating:
Critically low
Loading...